All In MedTech

Device Trial Radar · NCT05014789

Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study

A Control-IQ Technology 2.0 Feasibility Study in Adult and Adolescent Subjects

Last checked: Nov 19, 2026Latest source record: Jun 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

66

Actual

Start

Aug 19, 2021

Primary completion

Dec 20, 2021

Study completion Dec 20, 2021

Sponsor

Lead sponsor
Tandem Diabetes Care, Inc.Public (TNDM)
Sponsor type
Industry
First posted
Aug 20, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to obtain preliminary safety and performance data on planned improvements to Control-IQ technology.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • Control-IQ technology 2.0Device

    All subjects wearing the t:slim X2 insulin pump with Control-IQ technology 2.0, and wearing the Dexcom G6 sensor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Percent Time Less Than 54 mg/dLTime frame: Data collected over 1 week for each intervention, up to 5 weeks
  2. Severe HypoglycemiaTime frame: Data collected over 1 week for each intervention, up to 5 weeks
  3. Diabetic KetoacidosisTime frame: Data collected over 1 week for each intervention, up to 5 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Virginia

    Charlottesville, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.